Seqster is a person-centric interoperability platform that draws from electronic health records, consumer genetic tests and wearables, and presents the data through an engaging user interface.
Along with its partners, Seqster enables individuals and their families to access and integrate generations of family health data on one digital platform. Launched in February 2018 by Ardy Arianpour and his partners, Dana Hosseini and Xiang Li, the company has racked up numerous awards, including the 2018 Exponential Medicine MEDy Award for Company to Watch, American Heart Association HealthTech Award and the World Frontiers Forum Pioneer of 2018.
Prior to his Seqster tenure, Arianpour launched several clinical and consumer-based genetic tests as CCO of Pathway Genomics and SVP of Ambry Genetics, which Konica Minolta bought for $1 billion in 2017. He was one of the main architects of the launch of the first commercial clinical exome sequencing test in 2011.
From the May 01, 2019 Issue of MM+M - Medical Marketing and Media
